20/20 NOW http://www.for2020now.com the innovator of Ocular Telehealth, announced that Artificial Intelligence (AI) is able to detect retinal disease early in patients with diabetic retinopathy. This is achieved by using 20/20 NOW FDA approved equipment and software capable of enhancing retinal images immediately using AI.
It has been found that only about half of persons with type 2 diabetes on average receive an annual eye exam. With the widespread epidemic of diabetes, optometrists can now work with 20/20 NOW’s Ocular Telehealth System to identify diabetic retinopathy and are able to refer patients much sooner for treatment to avoid complications.
According to the company’s advisor, Bryan M. Rogoff, OD, “By providing optometrists with AI to enhance retinal images, they are able to diagnose retinal disease with more confidence during a telehealth exam.”
In other news, RightEye LLC https://invisionmag.com, a company using eye tracking to revolutionize patient care to improve vision performance, just announced that the company’s vision system has received 510 (k) clearance from FDA to record, view, and analyze eye movements to then identify visual tracking impairment in patients and to correlate the eye movements to health issues.